טוען...
Successful treatment of atopic dermatitis with the JAK1 inhibitor oclacitinib
We report the first case of atopic dermatitis successfully treated with the oral Janus kinase-1 (JAK1) inhibitor oclacitinib. A man in his 70s, with a 6-year history of skin disease refractory to topical and biologic therapies, self-prescribed this veterinary medication with rapid remission of sympt...
שמור ב:
| הוצא לאור ב: | Proc (Bayl Univ Med Cent) |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Taylor & Francis
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6413965/ https://ncbi.nlm.nih.gov/pubmed/30949000 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/08998280.2018.1480246 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|